Erudio Healtherudio.com
Drug
XmAb819 trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying xmAb819: XmAb819-01. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| XmAb819-01 NCT05433142 · Xencor, Inc. | relapsed or refractory clear cell renal cell carcinoma | Phase 1 | 294 | 88 | Standard | Nov 3, 2026 | Preview |